Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
US |
|
A
|
Airgain Inc
F:6LV
|
US |
|
Sappi Ltd
F:SPI
|
ZA |
|
Siemens AG
F:SIE
|
DE |
|
Amadeus IT Group SA
F:AI3A
|
ES |
|
S
|
Stanley Black & Decker Inc
DUS:SWF
|
US |
|
Skymark Airlines Inc
F:7SA
|
JP |
|
G Willi Food International Ltd
F:D4V
|
IL |
|
L
|
Landstar System Inc
F:LDS
|
US |
|
Propel Holdings Inc
F:8KO
|
CA |
|
Vir Biotechnology Inc
NASDAQ:VIR
|
US |
|
Truworths International Ltd
F:IUE
|
ZA |
|
Aeon Co Ltd
TSE:8267
|
JP |
|
Infosys Ltd
NYSE:INFY
|
IN |
|
G
|
General Dynamics Corp
DUS:GDX
|
US |
|
A
|
Acom Co Ltd
F:AK5
|
JP |
|
L
|
L'Oreal SA
XMUN:LOR
|
FR |
|
C
|
CITIC Ltd
F:CPF
|
CN |
|
S
|
Swisscom AG
SWB:SWJA
|
CH |
|
Mega Uranium Ltd
F:M6J
|
CA |
|
Abb Ltd
MIL:1ABB
|
CH |
|
D
|
Deutsche Telekom AG
F:DTE
|
DE |
|
C
|
Ciena Corp
LSE:0HYA
|
US |
|
C
|
Ciena Corp
XMUN:CIE1
|
US |
Bankruptcy Probability
Vertex Pharmaceuticals Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Vertex Pharmaceuticals Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
129.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
369.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
186.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
127.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
82.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
467.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
212.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
69B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
53.5B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
85.4B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
53.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Vertex Pharmaceuticals Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Vertex Pharmaceuticals Inc has no debt.
You can find a full breakdown on its Balance Sheet.